Gene: MAP2K7 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5609
Gene Symbol: MAP2K7
MAP2K7 		0.020 Biomarker disease BEFREE As these targetable mutations warrant prospective research, the authors will be conducting a national National Cancer Institute-sponsored multicenter clinical trial to investigate BRAF/MEK inhibition in the treatment of craniopharyngioma. 27903124 2016
Entrez Id: 5609
Gene Symbol: MAP2K7
MAP2K7 		0.020 Biomarker disease BEFREE The advent of targeted therapy of the BRAF/MEK pathway is associated with new therapeutic opportunities for patients with craniopharyngiomas. 29952427 2018